{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:56:18Z","timestamp":1773982578513,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MD017816"],"award-info":[{"award-number":["R01MD017816"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002567","name":"American Academy of Allergy Asthma and Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002567","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["K23AI163350"],"award-info":[{"award-number":["K23AI163350"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jacig.2024.100234","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T21:08:12Z","timestamp":1708463292000},"page":"100234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency"],"prefix":"10.1016","volume":"3","author":[{"given":"Anna M.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Elmoursi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel V.","family":"DiGiacomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megha","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Sing","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand S.","family":"Dighe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristhian","family":"Berrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Poznansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Iafrate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Naranbhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Balazs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiv","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn R.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Barmettler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2024.100234_bib1","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Boni1lla","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100234_bib2","series-title":"Inborn errors of immunity","author":"Cheraghi","year":"2021"},{"key":"10.1016\/j.jacig.2024.100234_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3466","article-title":"Primary antibody deficiencies","volume":"13","author":"Durandy","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jacig.2024.100234_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10875-020-00928-x","article-title":"Impact of SARS-CoV-2 pandemic on patients with primary immunodeficiency","volume":"41","author":"Delavari","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100234_bib5","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.jaip.2023.05.029","article-title":"Association of inborn errors of immunity with severe COVID-19 and post-acute sequelae of COVID-19","volume":"11","author":"Farmer","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2024.100234_bib6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/iid3.450","article-title":"COVID-19 infection in CVID patients: what we know so far","volume":"9","author":"Weifenbach","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jacig.2024.100234_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jacig.2024.100234_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41392-021-00514-6","article-title":"Auto-antibodies against type I IFNs are associated with severe COVID-19 pneumonia","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jacig.2024.100234_bib9","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80428","article-title":"Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies","volume":"12","author":"Cheetham","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.jacig.2024.100234_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/imr.13091","article-title":"Correlates of protection against SARS-CoV-2 infection and COVID-19 disease","volume":"310","author":"Goldblatt","year":"2022","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jacig.2024.100234_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266852","article-title":"Does a humoral correlate of protection exist for SARS-CoV-2? A\u00a0systematic review","volume":"17","author":"Perry","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jacig.2024.100234_bib12","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jaip.2022.03.017","article-title":"Response to severe acute respiratory syndrome coronavirus 2 initial series and additional dose vaccine in patients with predominant antibody deficiency","volume":"10","author":"Barmettler","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2024.100234_bib13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jaci.2021.08.016","article-title":"Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity","volume":"148","author":"Delmonte","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100234_bib14","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jaci.2022.04.002","article-title":"Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult\u00a0patients with inborn errors of immunity","volume":"149","author":"van Leeuwen","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100234_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1217718","article-title":"Response to SARS-CoV-2 initial series and additional dose vaccine in pediatric patients with predominantly antibody deficiency","volume":"14","author":"Tandon","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacig.2024.100234_bib16","unstructured":"Centers for Disease Control and Prevention, COVID-19 vaccines for people who are moderately or severely immunocompromised, Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/immuno.html. Accessed August 20, 2023."},{"key":"10.1016\/j.jacig.2024.100234_bib17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/infdis\/jiab593","article-title":"Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 vbaccines","volume":"225","author":"Naranbhai","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jacig.2024.100234_bib18","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.cell.2021.04.006","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jacig.2024.100234_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2024.100234_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100234_bib21","doi-asserted-by":"crossref","first-page":"e02257","DOI":"10.1128\/JCM.02257-20","article-title":"Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers","volume":"59","author":"Patel","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jacig.2024.100234_bib22","first-page":"1","article-title":"In search of the SARS-CoV-2 protection correlate: head-to-head comparison of two quantitative S1 Assays in pre-characterized oligo-\/asymptomatic patients","author":"Rubio-Acero","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jacig.2024.100234_bib23","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/jalm\/jfab080","article-title":"SARS-CoV-2 serology status detected by commercialized platforms distinguishes previous infection and vaccination adaptive immune responses","volume":"6","author":"Suhandynata","year":"2021","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.jacig.2024.100234_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates DM","year":"2015","journal-title":"Journal of Statistical Software"},{"key":"10.1016\/j.jacig.2024.100234_bib25","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2021-220408","article-title":"SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response","volume":"80","author":"Bonelli","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacig.2024.100234_bib26","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/annrheumdis-2021-220781","article-title":"SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity","volume":"80","author":"Mrak","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacig.2024.100234_bib27","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3899\/jrheum.211152","article-title":"Time since rituximab treatment is essential for developing a humoral response to COVID-19 mRNA vaccines in patients with rheumatic diseases","volume":"49","author":"Troldborg","year":"2022","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jacig.2024.100234_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1146841","article-title":"Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections","volume":"14","author":"Egri","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacig.2024.100234_bib29","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/art.42372","article-title":"American College of Rheumatology Guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: Version 5","volume":"75","author":"Curtis","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jacig.2024.100234_bib30","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1038\/s41467-021-26479-2","article-title":"Anti-spike antibody response to natural SARS-CoV-2 infection in the general population","volume":"12","author":"Wei","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/j.jacig.2024.100234_bib31","doi-asserted-by":"crossref","first-page":"101926","DOI":"10.1016\/j.eclinm.2023.101926","article-title":"Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK\u00a0healthcare workers: a cross-sectional analysis","volume":"58","author":"Martin","year":"2023","journal-title":"EClinicalMedicine"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324000304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324000304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T06:56:20Z","timestamp":1714978580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829324000304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2772829324000304"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100234","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100234"}}